Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update

Go back to Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update
(NASDAQ: TSHA) Delayed: 6.60 +0.18 (2.80%)
Previous Close $6.42    52 Week High
Open $6.50    52 Week Low
Day High $6.70    P/E N/A 
Day Low $6.47    EPS
Volume 2,099,987